MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate

American Journal of Clinical Nutrition

Volumn 91, Issue 5, 2010, Pages 1377-1386

  Lai, Chao Qiang ^a   Parnell, Laurence D ^a   Troen, Aron M ^a   Shen, Jian ^a   Caouette, Heather ^a   Warodomwichit, Daruneewan ^a   Lee, Yu Chi ^a   Crott, Jimmy W ^a   Qiu, Wei Qiao ^b   Rosenberg, Irwin H ^a   Tucker, Katherine L ^a   Ordovás, José M ^a  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FOLIC ACID; GENOMIC DNA; HOMOCYSTEINE; METHIONINE ADENOSYLTRANSFERASE; PYRIDOXINE;

ADULT; ANTHROPOMETRY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL STUDY; CONTROLLED STUDY; DNA DAMAGE; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; VITAMIN BLOOD LEVEL;

ADULT; AGED; BOSTON; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DNA DAMAGE; FEMALE; FOLIC ACID; GENETIC VARIATION; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MEMORY; METHIONINE ADENOSYLTRANSFERASE; MIDDLE AGED; PUERTO RICO; STROKE; VITAMIN B 6;

EID: 77951963869     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2009.28923     Document Type: Article

References (50)

1. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
2. Vasan RS, Beiser A, D'Agostino RB, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA 2003;289:1251-1257
3. Sánchez-Moreno C, Jiménez-Escrig A, Martín A. Stroke: roles of B vitamins, homocysteine and antioxidants. Nutr Res Rev 2009;22:49-67.
4. Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008;299:2027-2036
5. Viswanathan A, Raj S, Greenberg SM, et al. Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial. Neurology 2009;72:268-272
6. Bønaa KH, Njølstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 2006;354:1578-1588
7. Yi P, Melnyk S, Pogribna M, Pogribny I, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275:29318-29323
8. Wall RT, Harlan JM, Harker LA, Striker GE. Homocyst(e)ine-induced endothelial cell injur in vitro: a model for the study of vascular injury. Thromb Res 1980;18:113-121
9. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 1986;77:1370-1376
10. Chiang PK, Gordon RK, Tal J, et al. S-Adenosylmethionine and methylation. FASEB J 1996;10:471-480
11. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-3295 (Pubitemid 127634978)
12. Botto N, Andreassi MG, Manfredi S, et al. Genetic polymorphisms in folate and homocysteine metabolism as risk factors for DNA damage. Eur J Hum Genet 2003;11:671-678 (Pubitemid 37160988)
13. Shen J, Lai CQ, Mattei J, Ordovas JM, Tucker KL. Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr 2010;91:337-342
14. Ullegaddi R, Powers HJ, Gariballa SE. B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clin Sci (Lond) 2004;107:477-484 (Pubitemid 39506739)
15. Troen AM, Lutgens E, Smith DE, Rosenberg IH, Selhub J. The atherogenic effect of excess methionine intake. Proc Natl Acad Sci USA 2003;100:15089-15094 (Pubitemid 37518021)
16. Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 2001;74:723-729 (Pubitemid 33101791)
17. Liu C, Wang Q, Guo H, et al. Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine. J Nutr 2008;138:311-315 (Pubitemid 351213645)
18. Antoniades C, Shirodaria C, Leeson P, et al. MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009;119:2507-2515
19. Valli A, Carrero JJ, Qureshi AR, et al. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients. Clin Chim Acta 2008;395:106-110
20. Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacol Ther 1997;73:265-280 (Pubitemid 27224439)
21. Curran SP, Ruvkun G. Lifespan regulation by evolutionarily conserved genes essential for viability. PLoS Genet 2007;3:e56. (Pubitemid 46683464)
22. Lai CQ, Parnell LD, Lyman RF, Ordovas JM, Mackay TF. Candidate genes affecting Drosophila life span identified by integrating microarray gene expression analysis and QTL mapping. Mech Ageing Dev 2007;128:237-249
23. Lu SC, Alvarez L, Huang ZZ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci USA 2001;98:5560-5565 (Pubitemid 32435681)
24. Chamberlin ME, Ubagai T, Mudd SH, Levy HL, Chou JY. Dominant inheritance of isolated hypermethioninemia is associated with a mutation in the human methionine adenosyltransferase 1A gene. Am J Hum Genet 1997;60:540-546 (Pubitemid 27097601)
25. Surtees R, Leonard J, Austin S. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 1991;338:1550-1554
26. Lai CQ, Tucker KL, Parnell LD, et al. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. Diabetes 2008;57:809-816
27. Tucker KL, Mattei J, Noel SE, et al. The Boston Puerto Rican Health Study, a longitudinal cohort study on health disparities in Puerto Rican adults: challenges and opportunities. BMC Public Health 2010;10:107.
28. Scott TM, Peter I, Tucker KL, et al. The Nutrition, Aging, and Memory in Elders (NAME) Study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry 2006;21:519-528
29. American Diabetes Association. Standards of medical care in diabetes-2007. Diabetes Care 2007;30(suppl):S4-41.
30. Lee IM, Paffenbarger RS Jr. Physical activity and stroke incidence - the Harvard Alumni Health Study. Stroke 1998;29:2049-2054
31. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 1987;422:43-52.
32. Camp VM, Chipponi J, Faraj BA. Radioenzymatic assay for direct measurement of plasma pyridoxal 5′ - phosphate. Clin Chem 1983;29:642-644
33. Soldin SJ, Wan BS, Cherian AG. The measurement of creatinine: a comparison between the Beckman Creatinine Analyzer II and the Selective Analyzer GSA IID. Clin Biochem 1981;14:165-168
34. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143-149
35. Leinonen J, Lehtimäki T, Toyokuni S, et al. New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997;417:150-152
36. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet 2005;37:1217-1223
37. Excoffier L, Slatkin M. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 1995;12:921-927
38. Golden Helix Inc. HelixTree manual. Version 5.3.0. Available from: http://www.helixtree.com/SNP-Variation/Manual/manual.html (cited June 2008).
39. Falush D, Stephens M, Pritchard JK. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003;164:1567-1587
40. Lai CQ, Tucker KL, Choudhry S, et al. Population admixture associated with disease prevalence in the Boston Puerto Rican health study. Hum Genet 2009;125:199-209.
41. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc B 1964;26:211-252
42. Purohit V, Abdelmalek MF, Barve S, et al. Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. Am J Clin Nutr 2007;86:14-24.
43. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9.
44. Komatsu S, Yanaka N, Matsubara K, Kato N. Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta 2003;1647:127-130
45. Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55:131-138
46. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291:565-575
47. Spence JD, Bang H, Chambless LE, Stampfer MJ. Vitamin Intervention For Stroke Prevention trial: an efficacy analysis. Stroke 2005;36:2404-2409
48. Dobson JG Jr, Fray J, Leonard JL, Pratt RE. Molecular mechanisms of reduced beta-adrenergic signaling in the aged heart as revealed by genomic profiling. Physiol Genomics 2003;15:142-147
49. Schweitzer NB, Alessio HM, Hagerman AE, et al. Access to exercise and its relation to cardiovascular health and gene expression in laboratory animals. Life Sci 2005;77:2246-2261
50. Westhoff TH, Scheid S, Tölle M, et al. A physiogenomic approach to study the regulation of blood pressure. Physiol Genomics 2005;23:46-53.